Basílico et al., 2005 - Google Patents
UV-specific DNA repair recombinant fusion enzyme: A new stable pharmacologically active principle suitable for photoprotectionBasílico et al., 2005
View PDF- Document ID
- 1042635702781572046
- Author
- Basílico G
- Roger C
- Seigelchifer M
- Kerner N
- Publication year
- Publication venue
- Journal of dermatological science
External Links
Snippet
BACKGROUND:: UV radiation can produce mutations in skin cells and correlates strongly with the onset of actinic keratoses and basal and squamous cell carcinomas. Xeroderma pigmentosum (XP) is a heritable disease characterized by an extreme sensitivity of skin to …
- 102000004190 Enzymes 0 title abstract description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Berta et al. | Genetic evidence equating SRY and the testis-determining factor | |
Horii et al. | Regulation of SOS functions: purification of E. coli LexA protein and determination of its specific site cleaved by the RecA protein | |
KR101685551B1 (en) | A composition for treating, preventing or improving central or peripheral nervous system related diseases | |
CN116115629A (en) | Nucleic acid products and methods of administration thereof | |
Havell et al. | Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation. | |
Bognar et al. | Primary structure of the Escherichia coli folC gene and its folylpolyglutamate synthetase-dihydrofolate synthetase product and regulation of expression by an upstream gene. | |
JP2018506542A (en) | Nucleic acid product and administration method thereof | |
Razin et al. | Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin | |
KR101726390B1 (en) | Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs | |
BR9806866A (en) | Expression cassette and its use, expression cassette strain, nucleic acid vector, viral strain, pharmaceutical composition, and, processes to study the function of one or more heterologous genes in a eukaryotic cell, to produce an hsv strain, for treating the human or animal body and for performing gene therapy on a human or animal, and, vaccine. | |
Hermansson et al. | Inter-helical hydrogen bond formation during membrane protein integration into the ER membrane | |
Basílico et al. | UV-specific DNA repair recombinant fusion enzyme: A new stable pharmacologically active principle suitable for photoprotection | |
ATE402995T1 (en) | ACT-3 NUCLEIC ACID, POLYPEPTIDES AND THEIR USE | |
Roerig et al. | Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters | |
Silva et al. | Cloning, overexpression, and purification of functional human purine nucleoside phosphorylase | |
Slack et al. | Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system | |
Boothman et al. | Isolation of an X-Ray-Responsive Element in the Promoter Region of Tissue-Type Plasmingoen Activator: Potential Uses of X-Ray-Responsive Elements for Gene Therapy | |
US20100322916A1 (en) | Dna repair polypeptides and methods of delivery and use | |
Lin et al. | Reconstitution of nucleotide excision nuclease with UvrA and UvrB proteins from Escherichia coli and UvrC protein from Bacillus subtilis. | |
ES2295037T3 (en) | PROCEDURES THAT USE THE PARD KIS / PARD KID BACTERIAL TOXIN / ANTITOXIN SYSTEM TO DESTRUCT EUCARIOT CELLS. | |
Singhal et al. | The role of PKCα and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer | |
Panayiotou et al. | Evidence of an intact N-terminal translocation sequence of human mitochondrial adenylate kinase 4 | |
Furlong et al. | The large subunit of herpes simplex virus type 1 ribonucleotide reductase: expression in Escherichia coli and purification | |
Oppenheim et al. | The product of gene P of coliphage λ | |
Krug et al. | Properties of the ISG15 E1 enzyme UbE1L |